Core Viewpoint - The company has received regulatory approval for its Ken-Valve and LuX-Valve Plus products in New Zealand, which will accelerate its global commercialization efforts [1] Group 1: Product Approval - The Ken-Valve and LuX-Valve Plus have recently obtained registration approval from the New Zealand Medicines and Medical Devices Safety Authority [1] - The approval is expected to enhance the company's market presence and facilitate the commercialization of these products in New Zealand [1] Group 2: Market Recognition - The products have gained widespread recognition in the market due to their design advantages, ongoing clinical trials, and continuous therapy promotion efforts [1] - The successful registration of these two key products aligns with the company's long-term strategic goals [1]
健世科技-B(09877.HK)：Ken-Valve和LuX-Valve Plus获得新西兰注册批准